Century Therapeutics, Inc.

For the period ended Dec 31, 2025. Filed Mar 12, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 12, 2026

IPSC$1.81+7.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

**(**In thousands, except share and per share amounts)


· · · ·
· · December 31, 2025 · · December 31, 2024
Assets

Current assets
Cash and cash equivalents	$61,853	$58,441
Short-term investments	55,261	130,851
Prepaid expenses and other current assets	3,655	4,759
Total current assets	120,769	194,051

Property and equipment, net	50,026	62,141
Operating lease right-of-use assets	16,139	28,706
Restricted cash	2,359	2,772
Long-term investments	—	30,818
Intangible assets	34,200	34,200
Security deposits and non-current assets	211	528
Total assets	$223,704	$353,216

Liabilities and stockholders’ equity

Current liabilities
Accounts payable	$4,773	$3,075
Accrued expenses and other liabilities	11,676	17,461
Contingent consideration liability, short-term	3,757	—
Deposit liability	20	82
Deferred revenue, current	—	109,164
Total current liabilities	20,226	129,782

Operating lease liability, long term	40,241	48,960
Contingent consideration liability	—	8,738
Deferred tax liability	4,301	4,374

Total liabilities	64,768	191,854

Commitments and contingencies (Note 9)
Stockholders' equity:
Preferred stock, $ 0.0001 par value, 10,000,000 shares authorized and 0 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectivel	—	—
Common stock, $0.0001 par value, 300,000,000 shares authorized; and 87,519,096 and 85,836,429 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively	9	9
Additional paid-in capital	950,814	943,366
Accumulated deficit	(791,917)	(782,337)
Accumulated other comprehensive Income	30	324
Total stockholders’ equity	158,936	161,362
Total liabilities and stockholders’ equity	$223,704	$353,216

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.